This site is intended for health professionals only

Home / News / SSPs: Remaining fluoxetine protocols extended into November

SSPs: Remaining fluoxetine protocols extended into November

By Costanza Pearce

30 Oct 2019

The two remaining serious shortage protocols (SSPs) issued to combat antidepressant shortages have been extended into November, the Pharmaceutical Services Negotiating Committee (PSNC) announced today (30 October).

The Government authorised its first three SSPs earlier this month (3 October), allowing community pharmacists in England to supply an alternative strength or formulation of fluoxetine to patients who had a prescription for the 10mg, 30mg and 40mg capsules.

The protocol covering fluoxetine 30mg capsules has been extended to 20 November 2019, while the protocol for fluoxetine 40mg capsules has a ‘revised end date’ of 11 November 2019, the negotiator announced.

The Department of Health and Social Care (DHSC) told The Pharmacist that the measures have been extended due to ongoing supply issues.

SSPs came into force in July through legislation that allows community pharmacists in England to provide appropriate alternatives to patients in the event of serious medicine shortages without having to go back to the patient’s GP for an updated script.

Last week (25 October), the SSP for fluoxetine 10mg capsules was withdrawn after stock returned to ‘sufficient’ levels.

All three SSPs were originally due to expire tomorrow (31 October).

The negotiator added: ‘Expiry dates may be brought forward or extended, and the content [of the protocols] may be amended throughout this period.

‘Pharmacists should ensure they are using the current version of an SSP before supplying an alternative product’, it stressed.

Up-to-date versions of SSPs can be found on the dedicated NHS Business Services Authority (NHSBSA) website.

Want news like this straight to your inbox?

Latest News

Stock shortages of fluoxetine 30mg capsules end after almost two years
The serious shortage protocol for fluoxetine 30mg capsules is finally coming to an end after...
Heart in hand
Benefits of statins outweigh risk of adverse events, study finds
The benefits of statins for primary cardiovascular disease (CVD) prevention outweigh a small risk of...
young people vaccinated
NHSE calls for young people to get jabbed as numbers wanting the vaccine plummet
People over the age of 18 are being urged by NHS officials to get their...